The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Trimipramine in Primary Insomnia: Results of a Polysomnographic Double-Blind Controlled Study
Abstract
In recent years, sedating antidepressants have been increasingly used to treat primary insomnia. Up to now, only one open pilot study with trimipramine and one double-blind placebo-controlled study with doxepin have provided scientific support for this approach in treating primary insomnia. In order to test the hypothesis that sedating antidepressants are useful in the treatment of primary insomnia, the effect of trimipramine on objectively and subjectively measured parameters of sleep was investigated in a double-blind placebo- and lormetazepam-controlled study in a sample of 55 patients with primary insomnia attending outpatient sleep-disorder clinics. Trimipramine was selected since it has shown positive effects on sleep continuity with a lack of REM sleep suppression in studies on depressed patients and in one pilot study on patients with primary insomnia. Trimipramine at an average dose of 100 mg over a period of 4 weeks significantly enhanced sleep efficiency, but not total sleep time (which had been the primary target variable) compared to placebo as measured by polysomnography. Changes in objective sleep parameters were paralleled by changes in subjective sleep parameters. Trimipramine did not suppress REM sleep. Lormetazepam decreased wake time and sleep stage 3 and increased REM sleep compared to placebo. After switching trimipramine to placebo, sleep parameters returned to baseline. There was no evidence of any rebound effect from trimipramine. Side effects from tr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence for their efficacy when used alone is relatively weak 38-42 and no specific agent within this group is recommended as preferable to the others in this group.”
From Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults (2008) · cites this paper as [39]
In the citing paper
“(Riemann et al., 2002) found that trimipramine (mean 100mg) was not associated with REM sleep suppression, when compared to placebo with insomnia patients.”
From Antidepressants and their effect on sleep (2005) · cites this paper as Riemann et al., 2002
In the citing paper
“REM sleep suppression is reported with all TCAs except trimipramine (Riemann et al., 2002).”
From Antidepressants and their effect on sleep (2005) · cites this paper as Riemann et al., 2002
Citations
Cites
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?
Ford, D. E. (1989) · JAMA · doi:10.1001/jama.262.11.1479 · Cited by 2,440
Effect of benzodiazepine hypnotics on all-night sleep EEG spectra.
Borbély, A. A., Mattmann, P., Loepfe, M., Strauch, I., & Lehmann, D. (1985) · PubMed · Cited by 230
Hajak, G., Rodenbeck, A., Voderholzer, U., Riemann, D., Cohrs, S., Hohagen, F., Berger, M., & Ruther, E. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0609 · Cited by 199
Self-citationTrimipramine: A challenge to current concepts on antidepressives
Berger, T., & Gastpar, M. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190274 · Cited by 190
REM sleep in depression—an overview
Berger, M., & Riemann, D. W. (1993) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1993.tb00092.x · Cited by 138
Self-citationLong-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia
Backhaus, J., Hohagen, F., Voderholzer, U., & Riemann, D. W. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170066 · Cited by 127
Self-citationGillin, J. C., Rapaport, M., Erman, M. K., Winokur, A., & Albala, B. J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0502 · Cited by 104
The Effects of Nefazodone on Sleep Architecture in Depression
Armitage, R., Rush, A. J., Trivedi, M., Cain, J., & Roffwarg, H. P. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.14 · Cited by 102
Armitage, R., Yonkers, K., Cole, D., & Rush, A. J. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199706000-00004 · Cited by 97
Cited by
Sorted by citations
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943
The hyperarousal model of insomnia: A review of the concept and its evidence
Riemann, D., Spiegelhalder, K., Feige, B., Voderholzer, U., Berger, M., Perlis, M., & Nissen, C. (2010) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2009.04.002 · Cited by 1,789
Self-citationSateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Sleep, insomnia, and depression
Riemann, D. W., Krone, L. B., Wulff, K., & Nissen, C. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0411-y · Cited by 901
Self-citationWilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Self-citationPsychiatric Disorders and Sleep
Krystal, A. D. (2012) · Neurologic Clinics · doi:10.1016/j.ncl.2012.08.018 · Cited by 386
Antidepressants and Sleep: A Qualitative Review of the Literature
Wilson, S., & Argyropoulos, S. (2005) · Drugs · doi:10.2165/00003495-200565070-00003 · Cited by 392
Antidepressants and their effect on sleep
Mayers, A. G., & Baldwin, D. S. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.726 · Cited by 323
Wilson, S., Anderson, K., Baldwin, D., Dijk, D.-J., Espie, A., Espie, C., Gringras, P., Krystal, A., Nutt, D., Selsick, H., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855343 · Cited by 312
REM Sleep Instability – A New Pathway for Insomnia?
Riemann, D. W., Spiegelhalder, K., Nissen, C., Hirscher, V., Baglioni, C., & Feige, B. (2012) · Pharmacopsychiatry · doi:10.1055/s-0031-1299721 · Cited by 254
Self-citationAntidepressants for insomnia in adults
Everitt, H., Baldwin, D. S., Stuart, B. L., Lipinska, G., Mayers, A., Malizia, A. L., Manson, C., & Wilson, S. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010753.pub2 · Cited by 225
Voderholzer, U., Al-Shajlawi, A., Weske, G., Feige, B., & Riemann, D. (2003) · Depression and Anxiety · doi:10.1002/da.10101 · Cited by 206
Self-citationSateia, M. J., & Nowell, P. D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17480-1 · Cited by 194
Novel therapeutic usage of low-dose doxepin hydrochloride
Singh, H., & Becker, P. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.8.1295 · Cited by 27
Sleep and Antidepressant Treatment
Wichniak, A., Wierzbicka, A., & Jernajczyk, W. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523608 · Cited by 142
Drug Treatment of Primary Insomnia: A Meta-Analysis of Polysomnographic Randomized Controlled Trials
Winkler, A., Auer, C. J., Doering, B. K., & Rief, W. (2014) · CNS Drugs · doi:10.1007/s40263-014-0198-7 · Cited by 139
Buscemi, N., Vandermeer, B., Friesen, C., Bialy, L. M., Tubman, M., Ospina, M. B., Klassen, T. P., & Witmans, M. (2005) · PsycEXTRA Dataset · doi:10.1037/e439752005-001 · Cited by 134
Diagnosis and treatment of chronic insomnia
Saddichha, S. (2010) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.64628 · Cited by 137
Sleep disturbances in depression and the effects of antidepressants
Argyropoulos, S., & Wilson, S. J. (2005) · International Review of Psychiatry · doi:10.1080/09540260500104458 · Cited by 123
Antidepressants for the Treatment of Insomnia: A Suitable Approach?
Wiegand, M. H. (2008) · Drugs · doi:10.2165/0003495-200868170-00001 · Cited by 108
Self-citationRodenbeck, A., Cohrs, S., Jordan, W., Huether, G., R�ther, E., & Hajak, G. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1565-0 · Cited by 103
Self-citationKrystal, A. D., Richelson, E., & Roth, T. G. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.08.001 · Cited by 109
Histamine-1 receptor antagonism for treatment of insomnia.
Griend, J. V. V., & Anderson, S. L. (2012) · Journal of the American Pharmacists Association · doi:10.1331/japha.2012.12051 · Cited by 70
Pharmacologic treatment of pediatric insomnia.
Owens, J., & Moturi, S. (2009) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2009.04.009 · Cited by 81
Bruni, O., Angriman, M., Calisti, F., Comandini, A., Esposito, G., Cortese, S., & Ferri, R. (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12812 · Cited by 94
Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis
Winkler, A., & Rief, W. (2015) · SLEEP · doi:10.5665/sleep.4742 · Cited by 83
Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders
Bruni, O., Angriman, M., Melegari, M. G., & Ferri, R. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1674283 · Cited by 78
Zisapel, N. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.690735 · Cited by 71
Pharmacological Treatment of Insomnia
Schweitzer, P. K., & Feren, S. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-41400-3_7 · Cited by 68
Neuroscience-driven discovery and development of sleep therapeutics
Dresler, M., Spoormaker, V. I., Beitinger, P., Czisch, M., Kimura, M., Steiger, A., & Holsboer, F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.012 · Cited by 63
Update on the Safety Considerations in the Management of Insomnia With Hypnotics
Lieberman, J. A. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0105 · Cited by 61
Watson, N. F., Benca, R. M., Krystal, A. D., McCall, W. V., & Neubauer, D. N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072493 · Cited by 59
Sleep-Related Disorders in Neurology and Psychiatry
Rémi, J., Pollmächer, T., Spiegelhalder, K., Trenkwalder, C., & Young, P. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0681 · Cited by 65
Meta‐analysis of sleep changes in control groups of insomnia treatment trials
Bélanger, L., Vallières, A., Ivers, H., Moreau, V., Lavigne, G., & Morin, C. (2007) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2007.00566.x · Cited by 52
Hypnotika – Stand der Forschung
Nissen, C., Frase, L., Hajak, G., & Wetter, T. C. (2013) · Der Nervenarzt · doi:10.1007/s00115-013-3893-6 · Cited by 53
Self-citationPharmacologic Treatment of Primary Insomnia
Walsh, J. K., Roehrs, T., & Roth, T. G. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50070-7 · Cited by 52
Baghai, T. C., Blier, P., Baldwin, D. S., Bauer, M., Goodwin, G. M., Fountoulakis, K. Ν., Kasper, S. F., Leonard, B. E., Malt, U. F., Stein, D. J., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0259-6 · Cited by 51
Self-citationMaking sleep easier: pharmacological interventions for insomnia
Frase, L., Nissen, C., Riemann, D. W., & Spiegelhalder, K. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1511705 · Cited by 51
Self-citationOptimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons
Minkel, J., & Krystal, A. (2013) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2013.06.002 · Cited by 52
Antidepressant and Antipsychotic Drugs
Krystal, A. D. (2010) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2010.08.010 · Cited by 49
Liu, Y., Xu, X., Dong, M., Jia, S., & Wei, Y. (2017) · Sleep Medicine · doi:10.1016/j.sleep.2017.03.007 · Cited by 44
Pan, B., Ge, L., Lai, H., Hou, L., Tian, C., Wang, Q., Yang, K., Lü, Y., Zhu, H., Li, M., et al. (2023) · Drugs · doi:10.1007/s40265-023-01859-8 · Cited by 44
Prevalence and factors associated with off-label antidepressant prescriptions for insomnia
Lai, L., Tan, M. H., & Lai, Y.-C. (2011) · Drug, Healthcare and Patient Safety · doi:10.2147/dhps.s21079 · Cited by 46
Goforth, H. W., Preudʼhomme, X., & Krystal, A. D. (2014) · SLEEP · doi:10.5665/sleep.3760 · Cited by 40
Pharmacologic management of insomnia: past, present, and future.
Curry, D. T., Eisenstein, R. D., & Walsh, J. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.09.006 · Cited by 38
Cheaha, D., Keawpradub, N., Sawangjaroen, K., Phukpattaranont, P., & Kumarnsit, E. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.07.008 · Cited by 36
Clinical Pharmacology of Other Drugs Used as Hypnotics
Buysse, D. J., & Tyagi, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24288-2.00042-8 · Cited by 34
Pharmacologic Treatment of Primary Insomnia
Hall-Porter, J. M., Curry, D. T., & Walsh, J. K. (2010) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2010.08.006 · Cited by 31
Chronic tinnitus and associated sleep disturbances
Burgos, I., Feige, B., Hornyak, M., Härter, M., Weske-Heck, G., Voderholzer, U., & Riemann, D. (2005) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1111/j.1439-054x.2005.00056.x · Cited by 23
Self-citationThe effect of trimipramine on dream recall and dream emotions in depressive outpatients
Schredl, M., Berger, T., & Riemann, D. W. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.03.002 · Cited by 31
Self-citationIoachimescu, O., & El-Solh, A. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.683860 · Cited by 122
Low Risk for Switch to Mania during Treatment with Sleep Promoting Antidepressants
Wichniak, A., Jarkiewicz, M., Okruszek, Ł., Wierzbicka, A., Holka-Pokorska, J., & Rybakowski, J. (2015) · Pharmacopsychiatry · doi:10.1055/s-0034-1396802 · Cited by 28
Healthcare use in adults with insomnia: a longitudinal study.
Hayward, R., Jordan, K., & Croft, P. (2010) · The British journal of general practice : the journal of the Royal College of General Practitioners · doi:10.3399/bjgp10x501822 · Cited by 30
Doerr, J. P., Spiegelhalder, K., Petzold, F., Feige, B., Hirscher, V., Kaufmann, R., Riemann, D. W., & Voderholzer, U. (2010) · Pharmacopsychiatry · doi:10.1055/s-0030-1249049 · Cited by 23
Self-citationNichterholsamer Schlaf und Insomnie
Riemann, D., Voderholzer, U., & Berger, M. (2003) · Der Nervenarzt · doi:10.1007/s00115-003-1524-3 · Cited by 18
Self-citationManagement of insomnia: update and new approaches
Riemann, D. W. (2010) · Nature and Science of Sleep · doi:10.2147/nss.s6642 · Cited by 23
Self-citationClinical Sleep–Wake Disorders II: Focus on Insomnia and Circadian Rhythm Sleep Disorders
Spiegelhalder, K., Nissen, C., & Riemann, D. W. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_40 · Cited by 20
Self-citationDie Bedeutung des Schlafs für gesunde Alkoholkonsumenten und alkoholabhängige Patienten
Gann, P. H., van Calker, D., Feige, B., & Riemann, D. (2004) · Der Nervenarzt · doi:10.1007/s00115-003-1637-8 · Cited by 16
Self-citationThe guidelines for ‘non-restorative sleep’: Relevance for the diagnosis and therapy of insomnia
Riemann, D., Fischer, J., Mayer, G., & Peter, H. J. (2003) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1046/j.1439-054x.2003.03201.x · Cited by 17
Self-citationRiemann, D. W., & Hajak, G. (2009) · Der Nervenarzt · doi:10.1007/s00115-009-2746-9 · Cited by 17
Self-citationMolecular basis for the association between depression and circadian rhythm
Liu, I. Y., & Varinthra, P. (2019) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_181_18 · Cited by 16
Pediatric Sleep Pharmacology: A Primer
Troester, M. M., & Pelayo, R. (2015) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2015.03.002 · Cited by 15
Alcohol, toxins, and medications as a cause of sleep dysfunction
Conroy, D. A., & Brower, K. J. (2010) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52006-7.00038-1 · Cited by 14
Using pharmacotherapy to address sleep disturbances in autism spectrum disorders
Mammarella, V., Orecchio, S., Cameli, N., Occhipinti, S., Marcucci, L., Meo, G. D., Innocenti, A., Ferri, R., & Bruni, O. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2267761 · Cited by 14
Nefazodone in primary insomnia: an open pilot study
Wiegand, M. H., Galanakis, P., & Schreiner, R. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.042 · Cited by 13
Self-citationSchlafstörungen bei Depression
Zimmermann, C., & Pfeiffer, H. (2006) · Der Nervenarzt · doi:10.1007/s00115-006-2111-1 · Cited by 10
Pharmacological Treatment of Insomnia
Attarian, H. P. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-662-1_14 · Cited by 9
Efficacy and Safety of Sleep-Promoting Agents
Roth, T., & Roehrs, T. (2008) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2008.03.001 · Cited by 9
Schlaf und Schlafstörungen beim alten Menschen
Schlitzer, J., Heubaum, S., & Frohnhofen, H. (2014) · Zeitschrift für Gerontologie und Geriatrie (Print) · doi:10.1007/s00391-014-0810-y · Cited by 8
Influence of low-dose doxepin on periodic leg movements in sleep in primary insomnia patients
Hornyak, M., Kopasz, M., Rodenbeck, A., Hajak, G., Riemann, D., & Voderholzer, U. (2005) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1111/j.1439-054x.2005.00050.x · Cited by 9
Self-citationDamm, J., Eser, D., Schüle, C., Möller, H. ‐., Rupprecht, R., & Baghai, T. C. (2009) · Der Nervenarzt · doi:10.1007/s00115-008-2660-6 · Cited by 9
Self-citationDrug-induced sleep: theoretical and practical considerations
Ellenbogen, J. M., & Pace-Schott, E. F. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-1033-3 · Cited by 8
Clinical Pharmacology of Other Drugs Used as Hypnotics
Buysse, D. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00043-8 · Cited by 8
Feren, S. D., Schweitzer, P., & Walsh, J. (2011) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52007-4.00005-9 · Cited by 3
Pharmacological Treatment of Insomnia
Schweitzer, P. K., Curry, D. T., Eisenstein, R. D., & Walsh, J. K. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-042-7_23 · Cited by 9
Schlaf und seine Störungen im Alter
Happe, S. (2011) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-011-1371-5 · Cited by 7
Schlaf und Schlafstörungen beim alten Menschen
Frohnhofen, H., & Schlitzer, J. (2015) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-015-0901-4 · Cited by 7
Effects of different antidepressant treatments on the core of depression
Baghai, T. C., Eser, D., & Möller, H. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.3/tcbaghai · Cited by 7
Self-citationSchlaf und seine Störungen im Alter
Happe, S. (2012) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-012-0564-y · Cited by 6
Sleep Pharmacogenetics: The Promise of Precision Medicine.
Krystal, A., & Prather, A. (2019) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2019.05.003 · Cited by 6
Doerr, J., Spiegelhalder, K., & Riemann, D. (2007) · Psychiatrie und Psychotherapie up2date · doi:10.1055/s-2007-986230
Self-citationAntidepressant management of insomnia disorder in the absence of a mood disorder
Nazarian, P. K., & Park, S. H. (2014) · Mental Health Clinician · doi:10.9740/mhc.n188364 · Cited by 5
Medikamentöse Therapie des Schichtarbeitersyndroms
Hajak, G., & Rodenbeck, A. (2010) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-010-0465-x · Cited by 5
Self-citationHäufige schlafmedizinische Erkrankungen
Mayer, G. (2011) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-011-1376-0 · Cited by 4
Self-citationRiemann, D., Spiegelhalder, K., Hornyak, M., Berger, M., & Voderholzer, U. (2019) · Therapie psychischer Erkrankungen · doi:10.1016/b978-3-437-22485-0.00019-1
Self-citationNeuroleptika und Antidepressiva als Hypnotika. Wenn Nebenwirkungen zur Hauptwirkung werden
Enzensperger, C., & Lehmann, J. (2007) · Pharmazie in unserer Zeit · doi:10.1002/pauz.200600217 · Cited by 4
Schlaf und Schlafstörungen beim alten Menschen
Frohnhofen, H., Schlitzer, J., & Netzer, N. C. (2017) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-017-0102-z · Cited by 4
Chapter 82 – Pharmacologic Treatment: Other Medications
Krystal, A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00082-7
Efficacy and safety of non-pharmacological therapies for primary insomnia: a network meta-analysis
Zhang, Q., Liu, Y., Yang, G., Zhu, M.-Y., Yang, J.-H., Li, L., Yan, X., Liu, Q., Yue, J., Li, X., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1607903 · Cited by 3
Pigeon, W. R., Park, H., & Sateia, M. J. (2006) · Springer eBooks · doi:10.1007/0-387-27682-3_22 · Cited by 3
Restorative or Disruptive? Effects of Antidepressants on Sleep Architecture in Depression
Szynkarek, A., Tyrybon, W., Karcz, M., Lustyk, K., Sałaciak, K., & Pytka, K. (2026) · CNS Drugs · doi:10.1007/s40263-026-01297-6 · Cited by 4
Roles of peptides and steroids in sleep disorders
Steiger, A. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.5.609 · Cited by 3
Hypnotics: Definition, Classifications, Indications, and Differential Indications
Dietmaier, O. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_432 · Cited by 2
Pharmacology of Psychiatric Drugs and Their Effects on Sleep
Wilson, S. J. (2018) · Springer eBooks · doi:10.1007/978-3-642-54836-9_5 · Cited by 2
Krystal, A. D. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1703-7.10054-4 · Cited by 2
Hemmeter, U., Thum, A., & Krieg, J.-C. (2007) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-007-0306-8 · Cited by 2
Hypnotics: Guidelines and Current References
Bergemann, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_77 · Cited by 2
Medication for Sleep Problems in Posttraumatic Stress Disorder
de Jong, J., & Vermetten, E. H. G. J. M. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7148-0_29 · Cited by 2
Pharmakotherapie der Insomnien: State of the Art
Perlis, M. L., Spiegelhalder, K., Voderholzer, U., Hornyak, M., Klöpfer, C., Berger, M., Hajak, G., & Riemann, D. (2007) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-007-0300-1 · Cited by 2
Self-citationPsychoneuroendokrine Pathomechanismen der psychophysiologischen Insomnie
Rodenbeck, A., Hajak, G., Meier, A., Cohrs, S., & Jordan, W. (2005) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1111/j.1439-054x.2004.00041.x · Cited by 2
Self-citation
Metadata
- Authors
- Riemann, D., Voderholzer, U., Cohrs, S., Rodenbeck, A., Hajak, G., Rüther, E., Wiegand, M. H., Laakmann, G., Baghai, T., Fischer, W., Hoffmann, M., Hohagen, F., Mayer, G., & Berger, M.
- Affiliations
- University of Freiburg (DE)
- University of Göttingen (DE)
- Technical University of Munich (DE)
- Ludwig-Maximilians-Universität München (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Lübeck (DE)
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 2002-09
- Volume
- 35
- Issue
- 5
- Pages
- 165-174
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W1987429320
- Cited by
- 145
- References
- 11
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 1 · 2019: 8 · 2018: 4 · 2017: 8 · 2016: 3 · 2015: 7 · 2014: 7 · 2013: 11 · 2012: 8
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacopsychiatry (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- GRO (submittedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Keywords
- trimipramine, primary insomnia, sedating antidepressants, lormetazepam, sleep efficiency, REM sleep suppression, sleep continuity, rebound effect, antidepressant side effects
- MeSH terms
- Adult, Antidepressive Agents, Tricyclic, Benzodiazepines, Double-Blind Method, Female, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Lorazepam, Male, Middle Aged, Sleep Stages, Sleep, REM, Anti-Anxiety Agents, Trimipramine, Treatment Outcome, Polysomnography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
